Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Biogen stock whipsaws despite FDA granting full approval for Alzheimer
Stock Market

Biogen stock whipsaws despite FDA granting full approval for Alzheimer’s drug; analysts explain why By Investing.com

© Reuters. FDA converts Biogen and Eisai’s Alzheimer’s treatment to traditional approval The U.S. Food and Drug Administration (FDA) converted the approval status of Leqembi